European Organisation for Research and Treatment of Cancer
@eortc.org
We define better treatments for all cancer patients to prolong survival and improve quality of life.
👏 Earlier today at ISPOR Europe, our CEO Denis Lacombe moderated the plenary session “Pragmatic Trials — Bridging Research and Real-World Care”.
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
November 11, 2025 at 11:15 AM
👏 Earlier today at ISPOR Europe, our CEO Denis Lacombe moderated the plenary session “Pragmatic Trials — Bridging Research and Real-World Care”.
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
🔗 Read more: www.eortc.org/blog/2025/11...
#ISPOR #ClinicalResearch #EORTC #CancerCare #PragmaticTrials
🤝 We would like to thank all our contributors and supporters for the incredible support of Patient Days 2025, which took place last week.
Your engagement made it a truly meaningful event for everyone involved.
#PatientDays #EORTC
Your engagement made it a truly meaningful event for everyone involved.
#PatientDays #EORTC
November 10, 2025 at 2:47 PM
🤝 We would like to thank all our contributors and supporters for the incredible support of Patient Days 2025, which took place last week.
Your engagement made it a truly meaningful event for everyone involved.
#PatientDays #EORTC
Your engagement made it a truly meaningful event for everyone involved.
#PatientDays #EORTC
📢 EORTC is proud to join ISPOR Europe 2025!
CEO Denis Lacombe will moderate the plenary: “Pragmatic Trials — Bridging Research and Real-World Care”.
Posters by Fabio Borges, Maria Teixeira & Claire Piccinin.
🔗 www.eortc.org/blog/2025/11...
#HEOR #ClinicalTrials #ISPOREurope
CEO Denis Lacombe will moderate the plenary: “Pragmatic Trials — Bridging Research and Real-World Care”.
Posters by Fabio Borges, Maria Teixeira & Claire Piccinin.
🔗 www.eortc.org/blog/2025/11...
#HEOR #ClinicalTrials #ISPOREurope
November 10, 2025 at 12:15 PM
📢 EORTC is proud to join ISPOR Europe 2025!
CEO Denis Lacombe will moderate the plenary: “Pragmatic Trials — Bridging Research and Real-World Care”.
Posters by Fabio Borges, Maria Teixeira & Claire Piccinin.
🔗 www.eortc.org/blog/2025/11...
#HEOR #ClinicalTrials #ISPOREurope
CEO Denis Lacombe will moderate the plenary: “Pragmatic Trials — Bridging Research and Real-World Care”.
Posters by Fabio Borges, Maria Teixeira & Claire Piccinin.
🔗 www.eortc.org/blog/2025/11...
#HEOR #ClinicalTrials #ISPOREurope
🤝 As we close #PatientDays 2025, we reflect on the powerful exchanges that took place.
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
November 7, 2025 at 3:41 PM
🤝 As we close #PatientDays 2025, we reflect on the powerful exchanges that took place.
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
This event reaffirmed the importance of integrating patient perspectives into research and care.
Thank you to all who contributed to this meaningful dialogue.
#CancerResearch #ClinicalTrials
🎉 What a day at #EORTC #PatientDays!
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
November 6, 2025 at 4:15 PM
🎉 What a day at #EORTC #PatientDays!
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
Day 1 was packed with energy, empathy and honest round table talks.
Thanks to all who joined, your voices are shaping the future of cancer care.
👋 See you tomorrow!
🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology
This November, the EORTC Cancer Research Fund is putting patients at the heart of research.
From rare cancers to treatment optimisation, no patient is left behind.
Learn more: eortcresearchfund.org
#LeavingNoCancerPatientBehind
From rare cancers to treatment optimisation, no patient is left behind.
Learn more: eortcresearchfund.org
#LeavingNoCancerPatientBehind
November 6, 2025 at 1:46 PM
This November, the EORTC Cancer Research Fund is putting patients at the heart of research.
From rare cancers to treatment optimisation, no patient is left behind.
Learn more: eortcresearchfund.org
#LeavingNoCancerPatientBehind
From rare cancers to treatment optimisation, no patient is left behind.
Learn more: eortcresearchfund.org
#LeavingNoCancerPatientBehind
🤝 EORTC #PatientDays kicks off today in Brussels!
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
November 6, 2025 at 9:01 AM
🤝 EORTC #PatientDays kicks off today in Brussels!
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
Patients, caregivers & advocates meet Europe’s top cancer researchers to shape better treatment, care & quality of life.
🔗 Learn more: www.eortc.org/event/patien...
#CancerResearch #Oncology #ClinicalTrials
📢 New insights from PEACE-1
This post-hoc analysis examines how adjusting for abiraterone-prednisone cross-over impacts survival outcomes in de novo mCSPC.
A key step in refining trial interpretation.
🔗 Read more: www.eortc.org/publications/
#PEACE1 #ProstateCancer #ClinicalTrials #EORTC
This post-hoc analysis examines how adjusting for abiraterone-prednisone cross-over impacts survival outcomes in de novo mCSPC.
A key step in refining trial interpretation.
🔗 Read more: www.eortc.org/publications/
#PEACE1 #ProstateCancer #ClinicalTrials #EORTC
November 4, 2025 at 2:12 PM
📢 New insights from PEACE-1
This post-hoc analysis examines how adjusting for abiraterone-prednisone cross-over impacts survival outcomes in de novo mCSPC.
A key step in refining trial interpretation.
🔗 Read more: www.eortc.org/publications/
#PEACE1 #ProstateCancer #ClinicalTrials #EORTC
This post-hoc analysis examines how adjusting for abiraterone-prednisone cross-over impacts survival outcomes in de novo mCSPC.
A key step in refining trial interpretation.
🔗 Read more: www.eortc.org/publications/
#PEACE1 #ProstateCancer #ClinicalTrials #EORTC
📢New in Lung Cancer Journal!
A pan-European panel led by the #EORTClung reviews 105 clinical cases to define resectable stage III NSCLC for trial inclusion.
This consensus aims to improve patient selection and trial consistency across Europe.
🔗Read here: www.eortc.org/publications/
A pan-European panel led by the #EORTClung reviews 105 clinical cases to define resectable stage III NSCLC for trial inclusion.
This consensus aims to improve patient selection and trial consistency across Europe.
🔗Read here: www.eortc.org/publications/
October 30, 2025 at 2:38 PM
📢New in Lung Cancer Journal!
A pan-European panel led by the #EORTClung reviews 105 clinical cases to define resectable stage III NSCLC for trial inclusion.
This consensus aims to improve patient selection and trial consistency across Europe.
🔗Read here: www.eortc.org/publications/
A pan-European panel led by the #EORTClung reviews 105 clinical cases to define resectable stage III NSCLC for trial inclusion.
This consensus aims to improve patient selection and trial consistency across Europe.
🔗Read here: www.eortc.org/publications/
📢 Join our team in #Brussels!
The EORTC Projects and Services department is looking for a Project Manager.
Do you have a master’s degree, a 5-year experience in a project management role and are you looking for a new challenge?
👉 Apply now: www.eortc.org/job/project-...
#Jobs
The EORTC Projects and Services department is looking for a Project Manager.
Do you have a master’s degree, a 5-year experience in a project management role and are you looking for a new challenge?
👉 Apply now: www.eortc.org/job/project-...
#Jobs
October 29, 2025 at 11:23 AM
📢 Join our team in #Brussels!
The EORTC Projects and Services department is looking for a Project Manager.
Do you have a master’s degree, a 5-year experience in a project management role and are you looking for a new challenge?
👉 Apply now: www.eortc.org/job/project-...
#Jobs
The EORTC Projects and Services department is looking for a Project Manager.
Do you have a master’s degree, a 5-year experience in a project management role and are you looking for a new challenge?
👉 Apply now: www.eortc.org/job/project-...
#Jobs
📢 New publication alert!
EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in European Urology Oncology, highlighting radioligand therapy’s potential.
🔗 www.eortc.org/publications/
#EORTC #RENALUT #ccRCC
EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in European Urology Oncology, highlighting radioligand therapy’s potential.
🔗 www.eortc.org/publications/
#EORTC #RENALUT #ccRCC
October 24, 2025 at 2:23 PM
📢 New publication alert!
EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in European Urology Oncology, highlighting radioligand therapy’s potential.
🔗 www.eortc.org/publications/
#EORTC #RENALUT #ccRCC
EORTC’s RENALUT trial explores [177Lu]Lu-PSMA-617 in metastatic ccRCC. The protocol summary is now out in European Urology Oncology, highlighting radioligand therapy’s potential.
🔗 www.eortc.org/publications/
#EORTC #RENALUT #ccRCC
🙌 That’s a wrap on #ESMO25!
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
October 21, 2025 at 7:38 AM
🙌 That’s a wrap on #ESMO25!
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
EORTC shared new results and future trials focused on patient needs, long-term outcomes & treatment optimisation.
Thanks to all collaborators and patients who make this work possible.
🔗 Full summary: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
📢 Today is #WorldStatisticsDay, a moment to reflect on the tools that shape clinical research and medical progress.
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
October 20, 2025 at 9:42 AM
📢 Today is #WorldStatisticsDay, a moment to reflect on the tools that shape clinical research and medical progress.
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
Do you feel p-values satisfy the needs of clinical research in summarizing proof?
💬 Drop your thoughts in the comments, we’re reading!
Know more: www.eortc.org/blog/2025/10...
📢 Today we highlight a critical topic at #ESMO25: Eva Blondeaux presents on discontinuation and attrition in first-line RCTs for solid tumors.
What do these trends mean for trial design and patient outcomes?
Don't miss it! 🕥 10:45–10:50
#CancerResearch #EORTC #Oncology
What do these trends mean for trial design and patient outcomes?
Don't miss it! 🕥 10:45–10:50
#CancerResearch #EORTC #Oncology
October 20, 2025 at 8:31 AM
📢 Today we highlight a critical topic at #ESMO25: Eva Blondeaux presents on discontinuation and attrition in first-line RCTs for solid tumors.
What do these trends mean for trial design and patient outcomes?
Don't miss it! 🕥 10:45–10:50
#CancerResearch #EORTC #Oncology
What do these trends mean for trial design and patient outcomes?
Don't miss it! 🕥 10:45–10:50
#CancerResearch #EORTC #Oncology
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
October 19, 2025 at 10:15 AM
👉 We continue this exciting day at #ESMO25 with a spotlight on patient engagement!
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
Iryna Shakhnenko presents the EORTC framework, shaped by patients and professionals, to boost collaboration and improve research outcomes.
📢 Don't miss it!
#Oncology #PatientEngagement #EORTC
👏 Well done to Denis Lacombe for a compelling session today at #ESMO25!
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
October 19, 2025 at 8:51 AM
👏 Well done to Denis Lacombe for a compelling session today at #ESMO25!
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
Together, we’re shaping a future of cancer research that’s smarter and more inclusive.
#EORTC #CancerResearch #DEI #ClinicalTrials @myesmo.bsky.social
Today at #ESMO25, EORTC CEO Denis Lacombe speaks on two key challenges in cancer research:
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
October 19, 2025 at 6:31 AM
Today at #ESMO25, EORTC CEO Denis Lacombe speaks on two key challenges in cancer research:
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
➡️ Are we using therapies optimally in real-world care?
➡️ Are clinical trials truly inclusive of all patients?
Two sessions, one goal: research that’s both effective and equitable.
#ClinicalTrials #DEI
🚨 Big news from #EANO2025!
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
October 18, 2025 at 9:58 AM
🚨 Big news from #EANO2025!
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25!
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
October 17, 2025 at 3:38 PM
👏 Huge congrats to Madeline Pe for her fantastic presentation at #ESMO25!
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
Sharing key outcomes from the SISAQOL-IMI initiative and putting patient voices at the heart of cancer research.
Proud moment for EORTC! 📸
#QualityOfLife #EORTC #CancerResearch #GivingVoice2Patients @qol.eortc.org
📢 EORTC is hiring a Secretary for the Statistics Department (Replacement contract)
Organized, tech-savvy, and ready to support cancer research? Help our team with agendas, travel, meetings, presentations, and research project coordination.
📩 Apply now: www.eortc.org/job/secretar...
Organized, tech-savvy, and ready to support cancer research? Help our team with agendas, travel, meetings, presentations, and research project coordination.
📩 Apply now: www.eortc.org/job/secretar...
October 17, 2025 at 3:04 PM
📢 EORTC is hiring a Secretary for the Statistics Department (Replacement contract)
Organized, tech-savvy, and ready to support cancer research? Help our team with agendas, travel, meetings, presentations, and research project coordination.
📩 Apply now: www.eortc.org/job/secretar...
Organized, tech-savvy, and ready to support cancer research? Help our team with agendas, travel, meetings, presentations, and research project coordination.
📩 Apply now: www.eortc.org/job/secretar...
👏 We’re proud to see Madeline Pe, Head of EORTC #QualityofLife Department, present key insights from the SISAQOL-IMI initiative at #ESMO25.
Four years of work to improve how patient-reported outcomes are analysed in cancer trials.
📢 Catch her talk today at 14:35 in Berlin!
@qol.eortc.org
Four years of work to improve how patient-reported outcomes are analysed in cancer trials.
📢 Catch her talk today at 14:35 in Berlin!
@qol.eortc.org
October 17, 2025 at 11:52 AM
👏 We’re proud to see Madeline Pe, Head of EORTC #QualityofLife Department, present key insights from the SISAQOL-IMI initiative at #ESMO25.
Four years of work to improve how patient-reported outcomes are analysed in cancer trials.
📢 Catch her talk today at 14:35 in Berlin!
@qol.eortc.org
Four years of work to improve how patient-reported outcomes are analysed in cancer trials.
📢 Catch her talk today at 14:35 in Berlin!
@qol.eortc.org
ESMO 2025: A leadership moment!
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
October 17, 2025 at 11:02 AM
ESMO 2025: A leadership moment!
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.
Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.
📍We are in Berlin for #ESMO25. Come and visit us at our booth #S4040.
Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned!
👉 More info: www.eortc.org/blog/2025/10...
@myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation
Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned!
👉 More info: www.eortc.org/blog/2025/10...
@myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation
October 17, 2025 at 9:24 AM
📍We are in Berlin for #ESMO25. Come and visit us at our booth #S4040.
Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned!
👉 More info: www.eortc.org/blog/2025/10...
@myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation
Don't miss EORTC's upcoming sessions, mini-oral sessions, posters and more. Stay tuned!
👉 More info: www.eortc.org/blog/2025/10...
@myesmo.bsky.social #EORTC #ClinicalTrials #CancerResearch #Oncology #TreatmentOptimisation
🚀 EORTC is at #ESMO25!
As the Congress begins in Berlin, we’re proud to contribute with scientific presentations and expert insights.
Looking forward to a week of collaboration, innovation & progress in cancer research.
🔗 More info: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
As the Congress begins in Berlin, we’re proud to contribute with scientific presentations and expert insights.
Looking forward to a week of collaboration, innovation & progress in cancer research.
🔗 More info: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
October 17, 2025 at 9:09 AM
🚀 EORTC is at #ESMO25!
As the Congress begins in Berlin, we’re proud to contribute with scientific presentations and expert insights.
Looking forward to a week of collaboration, innovation & progress in cancer research.
🔗 More info: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
As the Congress begins in Berlin, we’re proud to contribute with scientific presentations and expert insights.
Looking forward to a week of collaboration, innovation & progress in cancer research.
🔗 More info: www.eortc.org/blog/2025/10...
#CancerResearch #ClinicalTrials
📢 @eanoassociation.bsky.social 2025 kicks off today in Prague!
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org
October 16, 2025 at 8:32 AM
📢 @eanoassociation.bsky.social 2025 kicks off today in Prague!
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org